New PRSS1 and common CFTR mutations in a child with acute recurrent pancreatitis, could be considered an "Hereditary" form of pancreatitis ? by Corleto, Vito D et al.
CASE REPORT Open Access
New PRSS1 and common CFTR mutations in a
child with acute recurrent pancreatitis, could be










2,5, Gianfranco Delle Fave
1
Abstract
Background: acute recurrent pancreatitis is a complex multigenic disease, the diagnosis is even more difficult
when this disease develops in a child.
Case Presentation: a 6-years old boy, hospitalized with epigastric pain radiating to the back showed high serum
levels of serum amylase, lipase, CRP and erythrosedimentation rate. Several similar milder episodes of pain, followed
by quick recovery and complete disappearance of symptoms were reported during the previous 13 months. The
child was medically treated and after 7 days with normal clinic and laboratory tests was discharged with a
hypolipidic diet. All the known aetiologic hypotheses were excluded by anamnestic investigation, clinical observation
and biochemical evaluation, whereas, anatomic abnormality were excluded by a secretin stimulated magnetic
resonance (MRI). At the last follow-up visit, (11 months later), the child showed a normal body weight and
anthropometric profile, without further abdominal pain. Mutation screening for coding regions of PRSS1, SPINK1, CFTR
and the new hereditary pancreatitis-associated chymotrypsin C (CTRC) genes showed a novel variation, c.541A >
G (p.S181G), in the exon 4 of PRSS1 gene and the classical CF p.F508del mutation in the CFTR. Both mutations were
present in his clinically normal mother and absent in the patient’s father.
Conclusions: this report extend the spectrum of PRSS1 mutations, however, the absence of family history of
pancreatitis leaves the present case without the hallmark of the hereditary origin of pancreatitis. At the present
knowledge it can be only stated that the combined genotype CFTR (F508del)/PRSS1 (S181G) is associated to a
mild phenotype of acute recurrent pancreatitis in this child without any further conclusion on its pathogenetic role
or prediction on the course of the disease.
Background
Hereditary Pancreatitis (HP) (OMIM #167800) is a rare
autosomal dominant disorder with about 80% of pene-
trance. The clinical features of HP patients consist in
attacks of acute pancreatitis, that in ~80% of individuals
starts before 20 years of age (median age 10 years). Pro-
gression to chronic pancreatitis also occurs in about ~50%
of patients and pancreatic cancer may develop by 15 years
of age in about ~40% of affected individuals [1,2]. In 1996,
a correlation was first reported between the development
of the disorder and hereditary factors with the PRSS1
gene, that encodes for the human cationic trypsinogen
[3,4]. Mutations and copy number variation (CNV) in the
PRSS1 gene are responsible for the increase of autocataly-
tic conversion of trypsinogen to active trypsin that leads to
autodigestion of the organ [5,6].
Chronic pancreatitis has also been associated with
mutations in other genes such as SPINK 1 (serine pro-
tease inhibitor Kazal Type I) [7], CFTR (Cystic Fibrosis
transmembrane conductance regulator) [8], CTRC
(chymotrypsin C) [9]. Contemporary mutations, in
these genes, trigger a distinctly greater risk of develop-
ing chronic pancreatitis [10-12]. While the polymorph-
ism p.G191R in PRSS2 (cationic trypsinogen type 2)
gene protects against chronic pancreatitis [13].
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heterozygous mutation in the PRSS1 gene, associated
with p.F508del mutation in CFTR, in a child presenting
acute recurrent pancreatitis.
Case Presentation
The case is described of a 6-year-old boy, examined in
the Emergency Department on account of acute abdom-
inal pain, intense nausea and mild fever (37.5°C). The
clinical history revealed 6 similar episodes during the
previous 13 months, some managed at home and other
with brief hospitalization. During the very first episode in
which he also presented a white blood count of 22,000
(88% neutrophils), appendicectomy was performed.
A review of previous medical charts revealed that amy-
lase had been evaluated only twice in the past and, on
both occasions, it was slightly increased (twice the nor-
mal value). However, no further investigation had been
performed due to rapid recovery and complete disappear-
ance of abdominal pain. When coming to our attention,
the boy appeared to be suffering, with knees drawn up to
his chest, and with epigastric pain radiating to his back,
of post-prandial onset. Furthermore, the child presented
moderate abdominal distension, however, all vital signs
were within normal limits. Laboratory studies were all
within the normal range, with the exception of serum
amylase which was 1373 U/L (n.v. 0-95 U/L), lipase 1050
U/L (n.v. 13-60 U/L), C-reactive protein (CRP) 95 mg/L
(n.v. 0-10 mg/L), erythrosedimentation rate (ESR)
74 mm/h (n.v. 0-20 mm/h). The child was treated with
intravenous (i.v.) fluids plus 20 mg of proton pump inhi-
bitor (PPI) i.v. An abdominal sonogram showed increased
pancreatic volume with diffuse oedema, gallbladder was
normal. The following day, laboratory tests showed over-
all decreased values: amylase 650 U/L, lipase 350 U/L,
CRP 30 mg/L. Fluids i.v. were administered for 4 days
after which amylase, lipase, CRP and ESR returned close
to normal values and a liquid light meal was administered
with good results. After 7 days of hospitalization, with
normal laboratory tests and without abdominal pain, the
child was discharged with a hypolipidic diet, 20 mg PPI
daily and pancreatic enzyme supplementation (10,000 U
× 6/day) per os. both for two more weeks. Taking into
consideration all the aetiologic hypotheses, blunt trauma,
metabolic, infectious, drug and systemic causes were
excluded, by means of accurate anamnestic investigations
and clinical observations and by further laboratory eva-
luations (calcium, glucose and triglycerides were always
normal; Mumps, Cytomegalovirus, Coxsackie B, Herpes
Simple virus antibodies were negative). In the attempt to
exclude any anatomic abnormality, secretin-stimulated
magnetic resonance imaging (MRI) of the pancreas was
programmed as an outpatient. At follow-up visits, the
child presented stable body weight, good appearance,
with no further episodes of abdominal pain, continuing a
strictly controlled of hypolipid diet. The secretin MRI,
performed 2 months later, showed an overall increased
thickness of the parenchyma of the entire pancreas with
aspecific irregular signal intensity in the head region.
Following secretin stimulation, the main pancreatic duct
appeared to be normal, with a normal papilla in the sec-
ond part of the duodenum that was normally filled,
10 minutes after the secretin infusion. At the last follow-
up visit, ~11 months after the last acute pancreatic
attach, the child presented a normal anthropometric pro-
file with normal body weight, and no further episodes of
abdominal pain were reported. However, two new short
episodes of abdominal pain have been recently reported
with a slight increase of only lipase levels (110 U/L; n.v.
13-60) following the last one.
Given the unexplained episode of pancreatitis in a
child, it was decided to investigate point mutations in
the cationic trypsinogen gene (PRSS1) underlying HP,
although no data were available suggesting familial pan-
creatitis in this patient. CFTR, SPINK-1 and the new
HP-associated chymotrypsin C (CTRC) gene were also
analysed. While genetic testing revealed normal SPINK1
and CTRC genes, a novel heterozygous variation,
c.541A > G (p.S181G), in exon 4 of PRSS1 gene was
revealed (Figure 1). This transition was never been
detected in 100 unrelated healthy controls, suggesting
that this variation is a putative mutation (http://www.
ncbi.nlm.nih.gov/sutils/blink.cgi?mode=result&pid). The
patient also showed the classic p.F508del mutation, in a
heterozygous state, in the CFTR gene. However, no
other nucleotide variations or genomic rearrangements
were detected in this gene following careful examina-
tion. Both mutations were absent in the patient’s father
but present in his clinically healthy mother.
To explain the discordance in phenotype, between
mother and proband, the following possibilities were
taken into consideration: i) presence, in the proband or
the father’s genome, of gross deletions/insertions in the
pancreatitis causative genes; ii) presence of active modi-
fier factors such as protective polymorphism p.G191R in
the PRSS2 gene; iii) non paternity, and iv) environmen-
tal effects.
To exclude the first hypothesis, we applied aCGH
(array-based Comparative Genomic Hybridization) to
detect macro deletions and macro insertions on the
entire genome of the father’s and proband’sD N A .N o
significant alterations were detected (data not shown).
The second and third hypotheses were ruled out by
complete sequence analysis of the PRSS2 gene and test-
ing of paternal micro-satellites (data not shown).
Furthermore, a detailed dietary history of the child
showed high frequency of consumption of fat food prior
to the onset of the acute pancreatitis episodes.
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The parents were constantly informed regarding the
interpretation of the clinical and genetic investigations
and always gave their written consent both to the proce-
dures and the laboratory investigations. PRSS1, PRSS2,
SPINK1, CTRC and CFTR coding regions amplification
and sequencing were performed on an ABI 3130
Genetic analyzer, according to previously reported con-
ditions [7,9,13-15], (Applied Biosystems; Foster City,
CA, USA).
Analysis of CFTR rearrangements was performed using
a quantitative PCR followed by capillary electrophoresis
(Multiplex ligation-dependent probe amplification,
MLPA SALSA Kit, MRC-Holland, The Netherlands).
aCGH was performed by Agilent’s Oligonucleotide
Array-Based CGH for Genomic DNA 4 × 44 K.
Discussion and Conclusions
The present case represents a rare condition in a child
with recurrent acute pancreatitis allegedly determined or
favoured by a compound heterozygous mutations,
p.F508del in CFTR and a novel maternal transmitted
mutation, p.S181G, in exon 4 of the PRSS1.T h i sr e p o r t
potentially extends the spectrum of the PRSS1 mutation.
In fact, all pancreatitis-associated PRSS1 mutations
discovered appear to cluster in the N-terminal half of
the molecule encoded by exons 2 and 3. Whereas, the
present p.S181G is the first mutation detected in exon
4 corresponding to an amino acid position inside two dis-
ulphide bridges, amino acids: 139-206 and 171-185.
Although it is well known that chronic pancreatitis is
predisposed by heterozygosity for CFTR mutations, little
is known about the combination of CFTR mutations with
PRSS1 or SPINK1 mutations. To date, only a few cases
have demonstrated that pancreatitis is caused by simulta-
neous CFTR and SPINK1 mutations (5.5%), of PRSS1 and
SPINK1 (1.3%), and of PRSS1 and CFTR (1.8%). No infor-
mation concerning clinical features of these patients are
available. Between 60% and 80% of HP patients carry a
pathogenic PRSS1 mutation. Lower penetrance and per-
haps, in some cases, modifier genes have been identified,
particularly the CFTR and SPINK1 [16].
In the present report, the combined genotype F508del/
S181G is associated with acute pancreatitis episodes in
the 6-year-old proband, but not in his 37-year-old
mother, who carries the same genotype, but without any
pancreatic symptoms, biochemical or ultrasound pan-
creatic alterations.
Following the experimental exclusion of gross dele-
tions/insertions in the pancreatitis causative genes in the
father, of a case of non paternity, and of the presence of
other mutations in pancreatitis relevant genes, it is
tempting to suggest that thep h e n o t y p i cd i s c o r d a n c e
may be due to unknown combination of genetic and/or
environmental factors.
Therefore, it could be a potential late onset of pancreatic
disease in the proband’s mother, or a case of incomplete
penetrance of a genotype composed by two mutations (up
to 20% of PRSS1 gene carriers may remain symptom-free)
[14]. In addition, it cannot be excluded that this genotype-
Figure 1 Sequence chromatogram of the PRSS1 mutation p.S181G.
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genes, relevant for the development of pancreatitis. On the
other hand, the finding that a hypolipidic diet has been
able to prevent any further pancreatic attack, suggests that
diet could have a great importance between the proband
and his mother phenotype. Similar cases of phenotypic
discordance represent an unresolved genetic aspect that
will be addressed in the future i.e. why some carriers of
PRSS1 mutation remain completely healthy whereas their
relatives with the same mutation develop various grade of
disease [1]. However, the absence of family history of pan-
creatitis leaves the present case without the hallmark of
the hereditary origin of pancreatitis in the present child. In
conclusion, functional studies are mandatory to under-
stand if and/or how PRSS1 mutation S181G could be
involved in determining recurrent pancreatitis or if it
needs to be combined with other HP causing genes such
as CFTR mutations. At the moment, the combined geno-
type F508del/S181G could be only associated to a mild
phenotype of acute recurrent pancreatitis as happened in
the present child. Moreover, on the base of the present
report we cannot establish whether PRSS1 S181G gene
mutation has a pathogenetic role on the child pancreatic
disease nor any prediction on the course of the disease.
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